Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Bone marrow-derived fibroblasts are a functionally distinct stromal cell population in breast cancer.

Raz Y, Cohen N, Shani O, Bell RE, Novitskiy SV, Abramovitz L, Levy C, Milyavsky M, Leider-Trejo L, Moses HL, Grisaru D, Erez N.

J Exp Med. 2018 Dec 3;215(12):3075-3093. doi: 10.1084/jem.20180818. Epub 2018 Nov 23.

PMID:
30470719
2.

To reappraise or not to reappraise? Emotion regulation choice and cognitive energetics.

Milyavsky M, Webber D, Fernandez JR, Kruglanski AW, Goldenberg A, Suri G, Gross JJ.

Emotion. 2018 Sep 20. doi: 10.1037/emo0000498. [Epub ahead of print]

PMID:
30234328
3.

Reverting the molecular fingerprint of tumor dormancy as a therapeutic strategy for glioblastoma.

Tiram G, Ferber S, Ofek P, Eldar-Boock A, Ben-Shushan D, Yeini E, Krivitsky A, Blatt R, Almog N, Henkin J, Amsalem O, Yavin E, Cohen G, Lazarovici P, Lee JS, Ruppin E, Milyavsky M, Grossman R, Ram Z, Calderón M, Haag R, Satchi-Fainaro R.

FASEB J. 2018 Jun 1:fj201701568R. doi: 10.1096/fj.201701568R. [Epub ahead of print]

PMID:
29856660
4.

Attenuated DNA damage responses and increased apoptosis characterize human hematopoietic stem cells exposed to irradiation.

Biechonski S, Olender L, Zipin-Roitman A, Yassin M, Aqaqe N, Marcu-Malina V, Rall-Scharpf M, Trottier M, Meyn MS, Wiesmüller L, Beider K, Raz Y, Grisaru D, Nagler A, Milyavsky M.

Sci Rep. 2018 Apr 17;8(1):6071. doi: 10.1038/s41598-018-24440-w.

5.

Replication stress in hematopoietic stem cells in mouse and man.

Flach J, Milyavsky M.

Mutat Res. 2018 Mar;808:74-82. doi: 10.1016/j.mrfmmm.2017.10.001. Epub 2017 Oct 18. Review.

PMID:
29079268
6.

Evidence for arrogance: On the relative importance of expertise, outcome, and manner.

Milyavsky M, Kruglanski AW, Chernikova M, Schori-Eyal N.

PLoS One. 2017 Jul 6;12(7):e0180420. doi: 10.1371/journal.pone.0180420. eCollection 2017.

7.

DNA-damage response in hematopoietic stem cells: an evolutionary trade-off between blood regeneration and leukemia suppression.

Biechonski S, Yassin M, Milyavsky M.

Carcinogenesis. 2017 Apr 1;38(4):367-377. doi: 10.1093/carcin/bgx002. Review.

PMID:
28334174
8.

Methylene Blue Assay for Estimation of Regenerative Re-Epithelialization In Vivo.

Milyavsky M, Dickie R.

Microsc Microanal. 2017 Feb;23(1):113-121. doi: 10.1017/S1431927617000101.

PMID:
28228166
9.

SMYD2 lysine methyltransferase regulates leukemia cell growth and regeneration after genotoxic stress.

Zipin-Roitman A, Aqaqe N, Yassin M, Biechonski S, Amar M, van Delft MF, Gan OI, McDermott SP, Buzina A, Ketela T, Shlush L, Xie S, Voisin V, Moffat J, Minden MD, Dick JE, Milyavsky M.

Oncotarget. 2017 Mar 7;8(10):16712-16727. doi: 10.18632/oncotarget.15147.

10.

Quercetin alters the DNA damage response in human hematopoietic stem and progenitor cells via TopoII- and PI3K-dependent mechanisms synergizing in leukemogenic rearrangements.

Biechonski S, Gourevich D, Rall M, Aqaqe N, Yassin M, Zipin-Roitman A, Trakhtenbrot L, Olender L, Raz Y, Jaffa AJ, Grisaru D, Wiesmuller L, Elad D, Milyavsky M.

Int J Cancer. 2017 Feb 15;140(4):864-876. doi: 10.1002/ijc.30497. Epub 2016 Nov 22.

11.

Erratum: Replication stress in MLL-rearrangements.

Milyavsky M, Gole B, Wiesmüller L.

Oncoscience. 2016 Apr 19;3(3-4):134. doi: 10.18632/oncoscience.303. eCollection 2016.

12.

Replication stress in MLL-rearrangements.

Milyavsky M, Gole B, Wiesmüller L.

Oncoscience. 2015 Dec 30;2(12):938-9. eCollection 2015. No abstract available. Erratum in: Oncoscience. 2016;3(3-4):134.

13.

The rocky road from attitudes to behaviors: Charting the goal systemic course of actions.

Kruglanski AW, Jasko K, Chernikova M, Milyavsky M, Babush M, Baldner C, Pierro A.

Psychol Rev. 2015 Oct;122(4):598-620. doi: 10.1037/a0039541. Epub 2015 Jul 20.

PMID:
26192134
14.

But what if the default is defaulting?

Hassin RR, Milyavsky M.

Behav Brain Sci. 2014 Feb;37(1):29-30. doi: 10.1017/S0140525X13000733. Epub 2014 Jan 24.

PMID:
24460987
15.

Lnk adaptor suppresses radiation resistance and radiation-induced B-cell malignancies by inhibiting IL-11 signaling.

Louria-Hayon I, Frelin C, Ruston J, Gish G, Jin J, Kofler MM, Lambert JP, Adissu HA, Milyavsky M, Herrington R, Minden MD, Dick JE, Gingras AC, Iscove NN, Pawson T.

Proc Natl Acad Sci U S A. 2013 Dec 17;110(51):20599-604. doi: 10.1073/pnas.1319665110. Epub 2013 Dec 2.

16.

Guess what? Implicit motivation boosts the influence of subliminal information on choice.

Milyavsky M, Hassin RR, Schul Y.

Conscious Cogn. 2012 Sep;21(3):1232-41. doi: 10.1016/j.concog.2012.06.001. Epub 2012 Jul 7.

PMID:
22776628
17.

Essential role for Ptpn11 in survival of hematopoietic stem and progenitor cells.

Chan G, Cheung LS, Yang W, Milyavsky M, Sanders AD, Gu S, Hong WX, Liu AX, Wang X, Barbara M, Sharma T, Gavin J, Kutok JL, Iscove NN, Shannon KM, Dick JE, Neel BG, Braun BS.

Blood. 2011 Apr 21;117(16):4253-61. doi: 10.1182/blood-2010-11-319517. Epub 2011 Feb 25.

18.

A distinctive DNA damage response in human hematopoietic stem cells reveals an apoptosis-independent role for p53 in self-renewal.

Milyavsky M, Gan OI, Trottier M, Komosa M, Tabach O, Notta F, Lechman E, Hermans KG, Eppert K, Konovalova Z, Ornatsky O, Domany E, Meyn MS, Dick JE.

Cell Stem Cell. 2010 Aug 6;7(2):186-97. doi: 10.1016/j.stem.2010.05.016. Epub 2010 Jul 8.

19.

A novel translocation breakpoint within the BPTF gene is associated with a pre-malignant phenotype.

Buganim Y, Goldstein I, Lipson D, Milyavsky M, Polak-Charcon S, Mardoukh C, Solomon H, Kalo E, Madar S, Brosh R, Perelman M, Navon R, Goldfinger N, Barshack I, Yakhini Z, Rotter V.

PLoS One. 2010 Mar 11;5(3):e9657. doi: 10.1371/journal.pone.0009657.

20.

Upregulation of survivin during immortalization of nontransformed human fibroblasts transduced with telomerase reverse transcriptase.

Yuan J, Yang BM, Zhong ZH, Shats I, Milyavsky M, Rotter V, Lock RB, Reddel RR, MacKenzie KL.

Oncogene. 2009 Jul 23;28(29):2678-89. doi: 10.1038/onc.2009.136. Epub 2009 Jun 1.

PMID:
19483728
21.

Spurious consensus and opinion revision: why might people be more confident in their less accurate judgments?

Yaniv I, Choshen-Hillel S, Milyavsky M.

J Exp Psychol Learn Mem Cogn. 2009 Mar;35(2):558-63. doi: 10.1037/a0014589.

PMID:
19271867
22.

Element-tagged immunoassay with ICP-MS detection: evaluation and comparison to conventional immunoassays.

Razumienko E, Ornatsky O, Kinach R, Milyavsky M, Lechman E, Baranov V, Winnik MA, Tanner SD.

J Immunol Methods. 2008 Jul 20;336(1):56-63. doi: 10.1016/j.jim.2008.03.011. Epub 2008 Apr 22.

23.

Amyloid-beta precursor-like protein APLP1 is a novel p53 transcriptional target gene that augments neuroblastoma cell death upon genotoxic stress.

Tang X, Milyavsky M, Goldfinger N, Rotter V.

Oncogene. 2007 Nov 15;26(52):7302-12. Epub 2007 May 28.

PMID:
17533371
24.

Myocardin in tumor suppression and myofibroblast differentiation.

Shats I, Milyavsky M, Cholostoy A, Brosh R, Rotter V.

Cell Cycle. 2007 May 15;6(10):1141-6. Epub 2007 May 9. Review.

PMID:
17495540
25.

Inactivation of myocardin and p16 during malignant transformation contributes to a differentiation defect.

Milyavsky M, Shats I, Cholostoy A, Brosh R, Buganim Y, Weisz L, Kogan I, Cohen M, Shatz M, Madar S, Kalo E, Goldfinger N, Yuan J, Ron S, MacKenzie K, Eden A, Rotter V.

Cancer Cell. 2007 Feb;11(2):133-46.

26.

Mutant p53 protects cells from 12-O-tetradecanoylphorbol-13-acetate-induced death by attenuating activating transcription factor 3 induction.

Buganim Y, Kalo E, Brosh R, Besserglick H, Nachmany I, Rais Y, Stambolsky P, Tang X, Milyavsky M, Shats I, Kalis M, Goldfinger N, Rotter V.

Cancer Res. 2006 Nov 15;66(22):10750-9.

27.

The promoters of human cell cycle genes integrate signals from two tumor suppressive pathways during cellular transformation.

Tabach Y, Milyavsky M, Shats I, Brosh R, Zuk O, Yitzhaky A, Mantovani R, Domany E, Rotter V, Pilpel Y.

Mol Syst Biol. 2005;1:2005.0022. Epub 2005 Oct 18.

28.

hTERT-immortalized prostate epithelial and stromal-derived cells: an authentic in vitro model for differentiation and carcinogenesis.

Kogan I, Goldfinger N, Milyavsky M, Cohen M, Shats I, Dobler G, Klocker H, Wasylyk B, Voller M, Aalders T, Schalken JA, Oren M, Rotter V.

Cancer Res. 2006 Apr 1;66(7):3531-40.

29.

Transcriptional programs following genetic alterations in p53, INK4A, and H-Ras genes along defined stages of malignant transformation.

Milyavsky M, Tabach Y, Shats I, Erez N, Cohen Y, Tang X, Kalis M, Kogan I, Buganim Y, Goldfinger N, Ginsberg D, Harris CC, Domany E, Rotter V.

Cancer Res. 2005 Jun 1;65(11):4530-43.

30.

p53-dependent down-regulation of telomerase is mediated by p21waf1.

Shats I, Milyavsky M, Tang X, Stambolsky P, Erez N, Brosh R, Kogan I, Braunstein I, Tzukerman M, Ginsberg D, Rotter V.

J Biol Chem. 2004 Dec 3;279(49):50976-85. Epub 2004 Sep 15.

31.

Activated p53 suppresses the histone methyltransferase EZH2 gene.

Tang X, Milyavsky M, Shats I, Erez N, Goldfinger N, Rotter V.

Oncogene. 2004 Jul 29;23(34):5759-69.

PMID:
15208672
32.

Hypoxia-dependent regulation of PHD1: cloning and characterization of the human PHD1/EGLN2 gene promoter.

Erez N, Stambolsky P, Shats I, Milyavsky M, Kachko T, Rotter V.

FEBS Lett. 2004 Jun 4;567(2-3):311-5.

33.

p53 mediates density-dependent growth arrest.

Meerson A, Milyavsky M, Rotter V.

FEBS Lett. 2004 Feb 13;559(1-3):152-8.

34.

p53 is a regulator of macrophage differentiation.

Matas D, Milyavsky M, Shats I, Nissim L, Goldfinger N, Rotter V.

Cell Death Differ. 2004 Apr;11(4):458-67.

35.

Expression of prolyl-hydroxylase-1 (PHD1/EGLN2) suppresses hypoxia inducible factor-1alpha activation and inhibits tumor growth.

Erez N, Milyavsky M, Eilam R, Shats I, Goldfinger N, Rotter V.

Cancer Res. 2003 Dec 15;63(24):8777-83.

36.

Prolonged culture of telomerase-immortalized human fibroblasts leads to a premalignant phenotype.

Milyavsky M, Shats I, Erez N, Tang X, Senderovich S, Meerson A, Tabach Y, Goldfinger N, Ginsberg D, Harris CC, Rotter V.

Cancer Res. 2003 Nov 1;63(21):7147-57.

37.

The murine telomerase catalytic subunit shares the PAb-240 mutant specific epitope of the p53 protein.

Shats I, Milyavsky M, Erez N, Rotter V.

FEBS Lett. 2003 Jul 10;546(2-3):321-4.

38.

Falkor, a novel cell growth regulator isolated by a functional genetic screen.

Erez N, Milyavsky M, Goldfinger N, Peles E, Gudkov AV, Rotter V.

Oncogene. 2002 Oct 3;21(44):6713-21.

39.

The onset of p53-dependent DNA repair or apoptosis is determined by the level of accumulated damaged DNA.

Offer H, Erez N, Zurer I, Tang X, Milyavsky M, Goldfinger N, Rotter V.

Carcinogenesis. 2002 Jun;23(6):1025-32.

PMID:
12082025
40.

Activation of p53 protein by telomeric (TTAGGG)n repeats.

Milyavsky M, Mimran A, Senderovich S, Zurer I, Erez N, Shats I, Goldfinger N, Cohen I, Rotter V.

Nucleic Acids Res. 2001 Dec 15;29(24):5207-15.

41.

Integrity of the N-terminal transcription domain of p53 is required for mutant p53 interference with drug-induced apoptosis.

Matas D, Sigal A, Stambolsky P, Milyavsky M, Weisz L, Schwartz D, Goldfinger N, Rotter V.

EMBO J. 2001 Aug 1;20(15):4163-72.

42.

The role of the C' terminus of murine p53 in the p53/mdm-2 regulatory loop.

Almog N, Milyavsky M, Stambolsky P, Falcovitz A, Goldfinger N, Rotter V.

Carcinogenesis. 2001 May;22(5):779-85.

PMID:
11323398
43.

Structural and functional involvement of p53 in BER in vitro and in vivo.

Offer H, Milyavsky M, Erez N, Matas D, Zurer I, Harris CC, Rotter V.

Oncogene. 2001 Feb 1;20(5):581-9.

44.

Change of the death pathway in senescent human fibroblasts in response to DNA damage is caused by an inability to stabilize p53.

Seluanov A, Gorbunova V, Falcovitz A, Sigal A, Milyavsky M, Zurer I, Shohat G, Goldfinger N, Rotter V.

Mol Cell Biol. 2001 Mar;21(5):1552-64.

45.

p53 modulates base excision repair activity in a cell cycle-specific manner after genotoxic stress.

Offer H, Zurer I, Banfalvi G, Reha'k M, Falcovitz A, Milyavsky M, Goldfinger N, Rotter V.

Cancer Res. 2001 Jan 1;61(1):88-96.

Supplemental Content

Loading ...
Support Center